Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1Phase 1 1

Status

Completed 106Recruiting 31Terminated 23Unknown 20Active not recruiting 20Withdrawn 4Not yet recruiting 4Enrolling by invitation 1Available 1

Sponsor Class

NIH 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 79Breast 11Thoracic 7Gynecologic 4Genitourinary 4Sarcoma 2CNS 2Other 1Lymphoid 1Head & Neck 1

Conditions

Ovarian Neoplasms 109Uterine Cervical Neoplasms 57Endometrial Neoplasms 38Fallopian Tube Neoplasms 34Carcinoma, Ovarian Epithelial 27Breast Neoplasms 25Neoplasms 15Carcinoma, Non-Small-Cell Lung 13Pancreatic Neoplasms 12Uterine Cervical Dysplasia 11Recurrence 11Stomach Neoplasms 10Neoplasm Metastasis 10Lung Neoplasms 9Colorectal Neoplasms 9Uterine Neoplasms 8Triple Negative Breast Neoplasms 8Sarcoma 8Urinary Bladder Neoplasms 7Melanoma 6Esophageal Neoplasms 6Vulvar Neoplasms 5Vaginal Neoplasms 5Testicular Neoplasms 5Lymphoma, Non-Hodgkin 5Small Cell Lung Carcinoma 4Sezary Syndrome 4Rectal Neoplasms 4Prostatic Neoplasms 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 4

Interventions

pidilizumab 1p53 peptide 264-272, human 1Metformin 1Mebendazole 1Doxycycline 1Atorvastatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Colonic Neoplasms × Gynecologic × Clear all
NCT02201381 2022-07-18

METRICS

Health Clinics Limited

Phase 3 Withdrawn
BreastCNSGastrointestinalGynecologic

Brain Neoplasms, Breast Neoplasms, Colonic Neoplasms, Neoplasm Metastasis, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Triple Negative Breast Neoplasms

NCT01095523 2017-07-02

Prospective Randomized Trial Evaluating Mandatory Second Look Surgery With HIPEC and CRS vs. Standard of Care in Subjects at High Risk of Developing Colorectal Peritoneal Metastases

National Institutes of Health Clinical Center (CC)

Phase 2 Withdrawn
GastrointestinalGynecologic

Colonic Neoplasms, Neoplasm Metastasis, Peritoneal Neoplasms, Rectal Neoplasms, Recurrence, Colorectal Neoplasms

NCT01176500 2017-07-02

A Pilot, Open-label Study of 18F-Fluciclatide PET/CT Imaging in the Evaluation of Anti-angiogenic Therapy in Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1/2 Withdrawn
GastrointestinalGenitourinaryGynecologicThoracic

Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Colonic Neoplasms, Lung Neoplasms, Uterine Neoplasms

NCT01386502 2017-07-02

CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Withdrawn
BreastGastrointestinalGynecologicSarcoma

Breast Neoplasms, Colonic Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡